These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11136375

  • 1. Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.
    Mondorf W, Klinge J, Luban NL, Bray G, Saenko E, Scandella D, Recombinate PUP Study Group.
    Haemophilia; 2001 Jan; 7(1):13-9. PubMed ID: 11136375
    [Abstract] [Full Text] [Related]

  • 2. Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.
    Klinge J, Auerswald G, Budde U, Klose H, Kreuz W, Lenk H, Scandella D, Paediatric Inhibitor Study Group of the German Society on Thrombosis and Haemostasis.
    Haemophilia; 2001 Jan; 7(1):26-32. PubMed ID: 11136377
    [Abstract] [Full Text] [Related]

  • 3. The natural history of the immune response to exogenous factor VIII in severe haemophilia A.
    Scandella D, Mondorf W, Klinge J.
    Haemophilia; 1998 Jul; 4(4):546-51. PubMed ID: 9873792
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P, Moore GW, Platton S, Maloney JC, Palmer B, Bowles L, Pasi KJ, Rangarajan S, Hart DP.
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA, Tucunduva AC, Siqueira LH, Sambo AL, Medina SS, Ozelo MC.
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [Abstract] [Full Text] [Related]

  • 7. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay.
    Sahud MA, Pratt KP, Zhukov O, Qu K, Thompson AR.
    Haemophilia; 2007 May; 13(3):317-22. PubMed ID: 17498082
    [Abstract] [Full Text] [Related]

  • 8. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
    Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G, Lee M.
    Blood; 1994 May 01; 83(9):2428-35. PubMed ID: 8167332
    [Abstract] [Full Text] [Related]

  • 9. Alloantibodies to factor VIII in haemophilia.
    Zakarija A, Harris S, Rademaker AW, Brewer J, Krudysz-Amblo J, Butenas S, Mann KG, Green D.
    Haemophilia; 2011 Jul 01; 17(4):636-40. PubMed ID: 21299745
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An ELISA assay for the detection of factor VIII antibodies - comparison with the conventional Bethesda assay in a large cohort of haemophilia samples.
    Shetty S, Ghosh K, Mohanty D.
    Acta Haematol; 2003 Jul 01; 109(1):18-22. PubMed ID: 12486318
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW, Chen LS, Jayakodi D, Dunkley SM.
    Thromb Res; 2013 Jul 01; 132(6):735-41. PubMed ID: 24119613
    [Abstract] [Full Text] [Related]

  • 17. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY, Kang SY, Lee WI.
    Korean J Lab Med; 2010 Jun 01; 30(3):260-3. PubMed ID: 20603586
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.
    Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH, Hemophilia Inhibitor Research Study Investigators, Hemophilia Inhibitor Research Study Investigators.
    J Thromb Haemost; 2015 Jan 01; 13(1):47-53. PubMed ID: 25354263
    [Abstract] [Full Text] [Related]

  • 19. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.
    Lindgren A, Wadenvik H, Tengborn L.
    Haemophilia; 2002 Sep 01; 8(5):644-8. PubMed ID: 12199673
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.